MD

Elastrin Therapeutics Announces Newly Formed Scientific Advisory Board

Retrieved on: 
Monday, January 17, 2022 - 11:40am
Biotechnology, Pharmaceutical, Health, Other Health, Linda, Clemson University, EDTA, Green College, Hotel des Indes (The Hague), VP, MAA, Industry, Therapy, Hospital, Grünenthal, LLC, Yuri, Health authority, NDA, Investment, Technology, Ageing, Conference, Pangborn Sensory Science Symposium, CTAS, Degenerative disease, Corporation, MBA, Cardiovascular disease, Health, Associate, Doctor of Philosophy, NICE, VC, Head, Elastin, United States Air Force Scientific Advisory Board, Patient, CMO, Chronic kidney disease, Reader, Mentorship, University, III, Board, Harvard Medical School, Winnipeg Regional Health Authority, Seminal vesicles, CEO, University of California, San Diego, MD, Calcification, Pharmaceutical industry, Management, Research, Brigham, Pediatrics, Medicine

Elastrin Therapeutics Inc., a privately held biotechnology company leveraging a platform technology to develop therapeutics that render calcified tissue and organs supple again, announced the formation of its Scientific Advisory Board.

Key Points: 
  • Elastrin Therapeutics Inc., a privately held biotechnology company leveraging a platform technology to develop therapeutics that render calcified tissue and organs supple again, announced the formation of its Scientific Advisory Board.
  • We are fortunate to work with such an amazing group of medical scientists, cardiovascular experts and pharma executives on our Scientific Advisory Board, said Dr. Matthias Breugelmans, CEO of Elastrin Therapeutics.
  • Elastrin is a prime example of what Kizoo is looking for in its investments: Not delaying an age-related disease but reversing it, said Patrick Burgermeister, Partner at Kizoo Technology Capital and member of Elastrin Therapeutics Board of Directors.
  • Elastrin Therapeutics Scientific Advisory Board is comprised of:
    Prof. Charles O'Neill, MD: Dr. ONeill has had an active basic and clinical research program in vascular calcification for the past 20 years and has published over 45 articles on this subject.

Digbi Health incorporates ethnic-relevant genetic risk scores to personalize care for metabolic and mental health conditions associated with gut and obesity

Retrieved on: 
Monday, January 17, 2022 - 11:06am
Income, Medicine, Genetic testing, Man, LinkedIn, Cancer, Arthritis, Inflammation, Bias, Population, Breast cancer, Jews, Food, BMI, Instagram, Health, Obesity, Hypertension, Smoking, Cardiovascular disease, Diabetes, Genetics, Atrial fibrillation, MD, Color, Risk, African Americans, Twitter, Lung cancer, Woman, Dietary supplement, Facebook

Despite the popularity, current genetic tests and digital care programs fail to account for gender and ethnic diversity.

Key Points: 
  • Despite the popularity, current genetic tests and digital care programs fail to account for gender and ethnic diversity.
  • Digbi's new genetic scores address these health outcome inequities and care is personalized using the member's ethnic ancestry, measured by their DNA sequence, gut microbiome, food habits, and food preference.
  • Digbi's science and care team is committed to eliminating health outcome disparities while advancing our understanding of genetic and gut microbiome science," said Ranjan Sinha, Founder and Chief Executive Officer of Digbi Health.
  • Digbi Health provides convenient, virtual care to people living with polychronic physical and mental illness associated with inflammatory gut and weight.

Lomiko Updates Private Placement

Retrieved on: 
Saturday, January 15, 2022 - 12:51am
Natural Resources, Energy, Environment, Mining, Minerals, Other Energy, Lithium, Board, Mineral, Eeyou Istchee James Bay Regional Government, SEDAR, Algonquin people, News, LMR, Legislation, Minority, Documentation, Technical report, National instrument, Unit, MI, No, First Nations, Kitigan Zibi Anishinabeg, Nemaska Lithium, Time, Techno-economic assessment, View, Industry, Outaouais, Algonquin Nation Programs and Services Secretariat, Company, Multilateral, TSX Venture Exchange, Metal, MD, National Financial Reporting Authority, TSX, FLI, Technology-critical element, Security (finance), Risk management, COVID-19

Further to the press release dated January 7, 2022, Lomiko Metals Inc. (TSX.V: LMR) (Lomiko Metals or the Company), subject to the approval of the TSX Venture Exchange for a non-brokered private placement, has updated the closing of its financing for gross proceeds of $1,666,000 through the issue of 20,825,000 units (Units) at a price of $0.08 per unit.

Key Points: 
  • Further to the press release dated January 7, 2022, Lomiko Metals Inc. (TSX.V: LMR) (Lomiko Metals or the Company), subject to the approval of the TSX Venture Exchange for a non-brokered private placement, has updated the closing of its financing for gross proceeds of $1,666,000 through the issue of 20,825,000 units (Units) at a price of $0.08 per unit.
  • The closing of the private placement is subject to the completion of formal documentation and the approval of the TSX Venture Exchange.
  • Proceeds of the private placement will be used for working capital.
  • The Company did not file a material change report 21 days prior to the closing date of this private placement as details of the respective participation of such insiders in the Offering was unknown at such time.

ISHLT Opens Registration for ISHLT2022 Annual Meeting and Scientific Sessions

Retrieved on: 
Friday, January 14, 2022 - 10:00pm
Research, Patient, Lung transplantation, MHS, International Society for Heart and Lung Transplantation, International Society, Annual, Annual general meeting, Review, Heart, Education, Transplant, MA, Multimedia, MPH, Dentistry, Medical device, MD

ADDISON, Texas, Jan. 14, 2022 /PRNewswire/ -- The International Society for Heart and Lung Transplantation (ISHLT) will host its 42nd Annual Meeting and Scientific Sessions on 27-30 April, 2022.

Key Points: 
  • ADDISON, Texas, Jan. 14, 2022 /PRNewswire/ -- The International Society for Heart and Lung Transplantation (ISHLT) will host its 42nd Annual Meeting and Scientific Sessions on 27-30 April, 2022.
  • "This year's ISHLT Annual Meeting promises to be one of our best conferences ever, offering a wide range of topics on advanced heart and lung disease," says Laurie Snyder, MD, MHS, ISHLT 2022 Scientific Program Chair.
  • "With over 1,400 scientific abstracts submitted, our scientific sessions represent the breadth and cutting-edge science of our field," says Dr. Snyder.
  • "On behalf of the ISHLT Board of Directors, we are looking forward to engaging with the worldwide ISHLT community at the upcoming Annual Meeting," says ISHLT President Lara Danziger-Isakov, MD, MPH.

U.S. FDA Approves Pfizer’s CIBINQO® (abrocitinib) for Adults with Moderate-to-Severe Atopic Dermatitis

Retrieved on: 
Friday, January 14, 2022 - 8:30pm
Biotechnology, FDA, Health, Pharmaceutical, Clinical Trials, Janus, Atopic dermatitis, New Drug Application, NDA, Patient, Food and Drug Administration, Week, Janus kinase 1, Pfizer, Dupilumab, Inc., Psoriasis Area and Severity Index, NYSE, Rash, Common, Adult, Nausea, CEO, JADE, Disease, Kidney failure, CYP2C19, AD, Department, George Washington University School of Medicine & Health Sciences, Headache, PFE, Inflammation, Outline of health sciences, Skin, Pain, JAK1, CYP, MD, Dermatitis, Food, Immunology, FDA, EASI, MPH, IGA, Pharmaceutical industry, P450, Safety, Doctor of Philosophy

Atopic dermatitis is so much more than just a rash, and it goes beyond the surface of the skin.

Key Points: 
  • Atopic dermatitis is so much more than just a rash, and it goes beyond the surface of the skin.
  • We appreciate Pfizers commitment to this resilient patient community and eagerly await the positive impact CIBINQO could have on the treatment landscape for moderate-to-severe atopic dermatitis.
  • Five clinical trials in the CIBINQO JAK1 Atopic Dermatitis Efficacy and Safety (JADE) global development program were included in the New Drug Application (NDA) to support the FDA approval.
  • Atopic dermatitis in America study: a cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the US adult population.

Online nominations are now open for Hozpitality's 5th Middle East Chef Excellence Awards to be held at the luxurious Address Sky View Dubai on 20th June 2022.

Retrieved on: 
Friday, January 14, 2022 - 8:24pm
Association, Airline, Popular, MEA, CEO, Panel, Emirates, Industry, Award, Year, MD, Restaurant, Hotel, ICCA

DUBAI, UAE, Jan. 14, 2022 /PRNewswire/ -- After 12 consecutive and successful award ceremonies in Middle East and Africa, Hozpitality Group is pleased to announce the 5th "Middle East Chef Excellence Awards" to be held on 20thJune 2022 at the luxurious Address Sky View Dubai. These awards are in association with the Emirates Culinary Guild Dubai and ICCA in Dubai.

Key Points: 
  • DUBAI, UAE, Jan. 14, 2022 /PRNewswire/ -- After 12 consecutive and successful award ceremonies in Middle East and Africa, Hozpitality Group is pleased to announce the 5th "Middle East Chef Excellence Awards" to be held on 20thJune 2022 at the luxurious Address Sky View Dubai.
  • These awards are in association with the Emirates Culinary Guild Dubai and ICCA in Dubai.
  • "As always, we will also have Young Chef Cook Off finals at the event and semi-finals will be held at our partner ICCA in Dubai on 9thJune 2022".
  • Hozpitality Group's Middle East Chef Excellence Awards - MEA recognizes the talented Chef within the industry from different categories and departments in the Middle East and Africa.

Online nominations are now open for Hozpitality's 5th Middle East Chef Excellence Awards to be held at the luxurious Address Sky View Dubai on 20th June 2022.

Retrieved on: 
Friday, January 14, 2022 - 8:22pm
Association, Airline, Popular, MEA, CEO, Panel, Emirates, Industry, Award, Year, MD, Hotel, Restaurant, ICCA

DUBAI, UAE, Jan. 14, 2022 /PRNewswire/ -- After 12 consecutive and successful award ceremonies in Middle East and Africa, Hozpitality Group is pleased to announce the 5th "Middle East Chef Excellence Awards" to be held on 20thJune 2022 at the luxurious Address Sky View Dubai.

Key Points: 
  • DUBAI, UAE, Jan. 14, 2022 /PRNewswire/ -- After 12 consecutive and successful award ceremonies in Middle East and Africa, Hozpitality Group is pleased to announce the 5th "Middle East Chef Excellence Awards" to be held on 20thJune 2022 at the luxurious Address Sky View Dubai.
  • These awards are in association with the Emirates Culinary Guild Dubai and ICCA in Dubai.
  • "As always, we will also have Young Chef Cook Off finals at the event and semi-finals will be held at our partner ICCA in Dubai on 9thJune 2022".
  • Hozpitality Group's Middle East Chef Excellence Awards - MEA recognizes the talented Chef within the industry from different categories and departments in the Middle East and Africa.

AIE's 225CS Engine Beats the Heat in AFRL Flight Testing

Retrieved on: 
Friday, January 14, 2022 - 8:10pm
Technology, Distortion, AFRL, Compact, National Energy Technology Laboratory, UAS, Temperature, National Environmental Engineering Research Institute, United States Air Force, Efficiency, ISR, MD, HP, UAV, AIE, Life, Electric motor

AIE demonstrated the capability of its 38 HP rotary engine, the AIE 225CS ( Compact SPARCS Self Pressurizing Air Rotor Cooling System ).

Key Points: 
  • AIE demonstrated the capability of its 38 HP rotary engine, the AIE 225CS ( Compact SPARCS Self Pressurizing Air Rotor Cooling System ).
  • "The SPARCS is an advanced rotor cooling system that substantially increases engine performance and its life.
  • In a week of flight testing, the AIE engine delivered outstanding climb and altitude performance.
  • The flight testing was considered a complete success, with one flight engineer commenting, "I have to say, this has been the smoothest engine install that I've ever been involved in.

NRx Responds to Relief’s Allegations of January 14, 2022

Retrieved on: 
Friday, January 14, 2022 - 7:34pm
Research, Fifth Amendment, Biology, Biotechnology, SEC, NASDAQ, Novartis, Development, JD, Israel Institute for Biological Research, US Foods, Biomedical Advanced Research and Development Authority, MPH, Complaint, Association, Defamation, National, COVID-19, National Security Advisor (United States), FINRA, History, Company, Food, FDA, Supreme court, Patient, Dark Enlightenment, J&J, Imprisonment, Fast Track, ASPE, Relief, Human services, United States Army, BARDA, Breakthrough therapy, Health, Relief Therapeutics, Lilly, Letter, GLOBE, ISA, Goal, Doctor of Science, Life insurance, Pharmaceutical industry, Allergan, Teva, Pfizer, MD

RADNOR, Pa., Jan. 14, 2022 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals(NASDAQ:NRXP), a clinical-stage biopharmaceutical company, responded to todays press release issued by Relief Therapeutics.

Key Points: 
  • RADNOR, Pa., Jan. 14, 2022 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals(NASDAQ:NRXP), a clinical-stage biopharmaceutical company, responded to todays press release issued by Relief Therapeutics.
  • Relief has accused NRx and its CEO of issuing false and misleading statements about the past actions of Reliefs Board and Management.
  • At no time has NRx accused any member of Reliefs board of current or past criminal activity.
  • NRx Pharmaceuticals (NRx) draws upon more than 300 years of collective, scientific, and drug-development experience to bring improved health to patients.

Winners Announced for the 2021 Senior Housing News Architecture and Design Awards

Retrieved on: 
Friday, January 14, 2022 - 6:00pm
Garden, International, Watermark, MI, Sheridan, IL, Walnut Creek, Architecture, CCRC, Industry, Red House, New York, Westwood, Los Angeles, Sherwood Park, Holbrook, Kolkata, Second Place, Ageing, Scripps Ranch, San Diego, CA, Continuing care retirement communities in the United States, Chesterfield Township, Kent Design Awards, Westwood, SHN, GA, Assisted living, River Forest, Third place, McHenry, Bethel, WI, News, Lite, Bronx River Parkway, Lowman, Lake Houston, LPC, Independent living, House, Stand, Hospice, Mayfield Heights, Ohio, Affordable housing, Jay Kristoff, MD, SC, Glen, Senior, CO, Residential care, Auction, Casino, Furniture, Hospital

CHICAGO, Jan. 14, 2022 /PRNewswire-PRWeb/ --Senior Housing News, an Aging Media Network publication, is pleased to announce the winners of the 9th annual Senior Housing News (SHN) Architecture & Design Awards ( http://www.shnawards.com ).

Key Points: 
  • CHICAGO, Jan. 14, 2022 /PRNewswire-PRWeb/ --Senior Housing News, an Aging Media Network publication, is pleased to announce the winners of the 9th annual Senior Housing News (SHN) Architecture & Design Awards ( http://www.shnawards.com ).
  • "This year's winning entries are a look at the future of senior living architecture and design," said George Yedinak, founder of Senior Housing News.
  • Senior Housing News (SHN) is the leading independent source for news and information covering senior housing and senior living.
  • About the SHN Architecture & Design Awards:
    The Senior Housing News Architecture & Design Awards recognize cutting-edge design, excellence and innovation in senior living.